Mesoblast Limited
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2016 | $-88.0M | $-88.0M | — | — |
| FY2017 | $-95.5M | $-95.5M | — | — |
| FY2018 | $-75.0M | $-75.0M | — | — |
| FY2019 | $-57.8M | $-57.8M | — | — |
| FY2020 | $-50.4M | $-50.4M | — | — |
| FY2021 | $-100.7M | $-100.7M | — | — |
| FY2022 | $-65.8M | $-65.8M | — | — |
| FY2023 | $-63.3M | $-63.5M | $264.0K | — |
| FY2024 | $-48.5M | $-48.7M | $271.0K | — |
| FY2025 | $-50.0M | $-50.6M | $680.0K | $9.2M |